

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | NF-κB ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ammonium pyrrolidine-1-carbodithioate | ✔ | 98% | |||||||||||||||||
| QNZ |
++++
NF-κB, IC50: 11 nM |
99%+ | |||||||||||||||||
| Sodium 4-Aminosalicylate Dihydrate | ✔ | 98% | |||||||||||||||||
| Sodium Salicylate | ✔ | 95% | |||||||||||||||||
| Parthenolide | ✔ | p53 | 97% HPLC | ||||||||||||||||
| JSH-23 |
+
NF-κB, IC50: 7.1 μM |
98% | |||||||||||||||||
| Phenethyl caffeate | ✔ | 98% | |||||||||||||||||
| Andrographolide | ✔ | 98+% | |||||||||||||||||
| Curcumin | ✔ | HDAC,Nrf2 | 98% | ||||||||||||||||
| SC75741 |
+++
NF-κB, EC50: 200 nM |
99%+ | |||||||||||||||||
| CBL0137 HCl |
++
NF-κB, EC50: 0.47 μM |
p53 | 99%+ | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Ethyl caffeate shows suppressesion of NF-κB activation and its downstream inflammatory mediators. It can be found in bidens pilosa. |
| Concentration | Treated Time | Description | References | |
| RAW 264.7 macrophages | 0.5-5 μg/ml | 6 hours | Inhibited iNOS mRNA and protein expression | Br J Pharmacol. 2005 Oct;146(3):352-63 |
| MCF-7 cells | 10-100 μg/ml | 6 hours | Inhibited TPA-induced cox-2 transcriptional activity | Br J Pharmacol. 2005 Oct;146(3):352-63 |
| RAW264.7 cells | 100 μM | 2 hours | Inhibited LPS-induced HMGB-1 protein secretion | Molecules. 2011 Nov 10;16(11):9451-66 |
| RAW 264.7 macrophages | 0.1-20 μg/ml | 24 hours | Inhibited LPS-induced NO production, IC50=5.5 μg/ml | Br J Pharmacol. 2005 Oct;146(3):352-63 |
| Mouse bone marrow-derived mast cells (BMMCs) | 10 μM | 24 hours | To evaluate the inhibitory effects of EC on DHNA-induced IL-6 production, results showed that EC inhibited DHNA-induced IL-6 production | Int J Mol Sci. 2023 Jun 10;24(12):9997 |
| Mouse bone marrow-derived mast cells (BMMCs) | 1 or 10 μM | 12 hours | To evaluate the inhibitory effects of EC on AhR protein downregulation, results showed that EC inhibited FICZ-induced downregulation of AhR protein levels | Int J Mol Sci. 2023 Jun 10;24(12):9997 |
| Mouse bone marrow-derived mast cells (BMMCs) | 1 or 10 μM | 2 hours | To evaluate the inhibitory effects of EC on AhR target gene expression, results showed that EC inhibited FICZ- or DHNA-induced Cyp1A1 mRNA expression | Int J Mol Sci. 2023 Jun 10;24(12):9997 |
| HeXS34 reporter cells | 10 μM | 12 hours | To evaluate the inhibitory effects of EC on AhR activation, results showed that EC significantly inhibited FICZ- or DHNA-induced SEAP activity | Int J Mol Sci. 2023 Jun 10;24(12):9997 |
| BALB/c splenocytes | 10 μM | 48 hours | To assess the effect of ECF on LPS-induced B cell proliferation, ECF inhibits B cell proliferation at 10 μM | J Immunol Res. 2017;2017:7416792 |
| Purified T cells | 0.1, 1, 10 μM | 48 hours | To assess the effect of ECF on TCR crosslinking-mediated T cell proliferation, ECF significantly inhibits T cell proliferation | J Immunol Res. 2017;2017:7416792 |
| BALB/c splenocytes | 0.1, 1, 10 μM | 48 hours | To assess the immunosuppressive effect of ECF in vitro, ECF significantly inhibits ConA-induced murine splenocyte proliferation | J Immunol Res. 2017;2017:7416792 |
| HCC827OR cells | 82 µM | 48 hours | Inhibited migration and proliferation of HCC827OR cells, promoted apoptosis, and downregulated MET expression | Cancer Cell Int. 2025 Mar 15;25(1):99 |
| PC9OR cells | 78 µM | 48 hours | Inhibited migration and proliferation of PC9OR cells, promoted apoptosis, and downregulated MET expression | Cancer Cell Int. 2025 Mar 15;25(1):99 |
| RAW264.7 cells | 75, 150, 300, 500 nM | 2 hours | To investigate the effect of Ethyl Caffeate on NO production in LPS-induced RAW264.7 cells, results showed that Ethyl Caffeate significantly reduced extracellular NO levels. | Front Pharmacol. 2022 Feb 23;13:801350 |
| RAW264.7 cells | 20, 50, 100 μM | 2 hours | Inhibited LPS-induced iNOS, IL-1β, and IL-10 mRNA expression | Molecules. 2011 Nov 10;16(11):9451-66 |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6 mice | Passive cutaneous anaphylaxis (PCA) model | Oral | 10 mg/kg | Single dose, evaluated after 24 hours | To evaluate the inhibitory effects of EC on PCA reaction, results showed that EC significantly inhibited ear swelling, Evans blue dye extravasation, and serum MCP-1 levels | Int J Mol Sci. 2023 Jun 10;24(12):9997 |
| DBA/1 mice | Collagen-induced arthritis model | Oral | 50 mg/kg | Once daily for 10 days | To investigate the antiarthritic potential of ECF, ECF treatment reduced the severity of CIA, inhibited IFN-γ and IL-6 secretion, and decreased the proportion of CD11b+Gr-1+ splenic neutrophil | J Immunol Res. 2017;2017:7416792 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.80mL 0.96mL 0.48mL |
24.01mL 4.80mL 2.40mL |
48.03mL 9.61mL 4.80mL |
|
| CAS号 | 102-37-4 |
| 分子式 | C11H12O4 |
| 分子量 | 208.21 |
| SMILES Code | O=C(OCC)/C=C/C1=CC=C(O)C(O)=C1 |
| MDL No. | MFCD00045754 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | WDKYDMULARNCIS-GQCTYLIASA-N |
| Pubchem ID | 5317238 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place,Inert atmosphere,2-8°C |
| 溶解方案 |
DMSO: 250 mg/mL(1200.71 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1